Literature DB >> 11887195

Clinical meaning of ascites in patients with endomyocardial fibrosis.

Antonio Carlos Pereira Barretto1, Charles Mady, Sergio Almeida Oliveira, Edmundo Arteaga, Creusa Dal Bo, José Antonio Franchini Ramires.   

Abstract

OBJECTIVE: To evaluate the clinical meaning of ascites and the main features of patients with ascites and endomyocardial fibrosis.
METHODS: We studied 166 patients with endomyocardial fibrosis (mean age 37 years, 114 women) treated over the last 20 years. Ventriculography findings, surgery or necropsy confirmed the diagnosis in all patients. Most patients belonged to New York Heart Association Functional Class III/IV (134, 83.7%). Eighty-one (50.6%) had biventricular, 28 (17.5%) had right ventricular, and 51 (31.8%) had left ventricular involvement. During follow-up, 56 patients died.
RESULTS: Ascites was present in 67 (41.8%) patients, and right ventricular involvement was present in 59 (88%). In the comparison between patients with or without ascites, those with ascites had higher mortality (49.2% and 24.7%, respectively). Patients with ascites had a higher incidence of edema (95% vs. 43%), hepatomegaly (5.8cm vs. 4.1cm), mean right atrium pressure (19.3 vs. 12mmHg), and final right ventricle diastolic pressure (18.7 vs. 12.9mmHg). Also, patients with ascites had a longer history of illness (5.1 and 3.9 years, respectively) and had atrial fibrillation more frequently (44.7% vs. 30.1%).
CONCLUSION: Ascites was observed in less than 50% of cases of endomyocardial fibrosis and was associated with greater involvement of the right ventricle and with a longer duration of the disease, thus being a characteristic of a worse prognosis.

Entities:  

Mesh:

Year:  2002        PMID: 11887195     DOI: 10.1590/s0066-782x2002000200008

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN: 0066-782X            Impact factor:   2.000


  4 in total

Review 1.  Endomyocardial fibrosis: past, present, and future.

Authors:  Andre Rodrigues Duraes; Yasmin de Souza Lima Bitar; Leonardo Roever; Mansueto Gomes Neto
Journal:  Heart Fail Rev       Date:  2020-09       Impact factor: 4.214

2.  Case 3/2015 - 53-year-old female with cardiogenic shock 12 years after surgical correction of endomyocardial fibrosis.

Authors:  Michel Abi Kalansky Ponczek; Fernanda Seligmann Feitosa; Léa Maria Macruz Ferreira Demarchi
Journal:  Arq Bras Cardiol       Date:  2015-09       Impact factor: 2.000

Review 3.  Heart failure in South America.

Authors:  Edimar Alcides Bocchi
Journal:  Curr Cardiol Rev       Date:  2013-05

4.  Case 5: a 73 year-old man with heart failure, preserved systolic function and associated renal failure.

Authors:  Tiago Rodrigues Politi; Paulo Sampaio Gutierrez
Journal:  Arq Bras Cardiol       Date:  2013-11       Impact factor: 2.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.